Literature DB >> 1294526

The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics.

U Jodal1.   

Abstract

Single-dose therapy has been documented in defined groups of adults. For children, this type of treatment requires further investigation. Children to be studied should have uncomplicated UTI and the drugs should optimally have a broad antibacterial spectrum, a low tendency to select for resistant bacteria, and pharmacokinetic properties allowing maintenance of inhibitory antibiotic levels in urine for at least two to three days. Fosfomycin trometamol, trimethoprim and co-trimoxazole are oral antibacterials that may prove effective for single-dose therapy in children, as has been suggested in some studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294526     DOI: 10.1007/bf01710023

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Epidemiology of symptomatic urinary tract infection in childhood.

Authors:  J Winberg; H J Andersen; T Bergström; B Jacobsson; H Larson; K Lincoln
Journal:  Acta Paediatr Scand Suppl       Date:  1974

2.  Level diagnosis of symptomatic urinary tract infections in childhood.

Authors:  U Jodal; U Lindberg; K Lincoln
Journal:  Acta Paediatr Scand       Date:  1975-03

3.  Short course antimicrobial treatment of urinary tract infections in children: a critical analysis.

Authors:  E D Shapiro
Journal:  Pediatr Infect Dis       Date:  1982 Sep-Oct

4.  Sequelae of covert bacteriuria in schoolgirls. A four-year follow-up study.

Authors: 
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

5.  Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children.

Authors:  P Careddu; M Borzani; F Varotto; L Garlaschi; P Fontana
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

6.  The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection.

Authors:  R Slack; D Greenwood
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

7.  Single dose antibiotic therapy is not as effective as conventional regimens for management of acute urinary tract infections in children.

Authors:  G Madrigal; C M Odio; E Mohs; J Guevara; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1988-05       Impact factor: 2.129

8.  The value of level diagnosis of childhood urinary tract infection in predicting renal injury.

Authors:  J Pylkkänen; J Vilska; O Koskimies
Journal:  Acta Paediatr Scand       Date:  1981-11

Review 9.  Management of children with unobstructed urinary tract infection.

Authors:  U Jodal; J Winberg
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

10.  Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.

Authors:  H Lomberg; L A Hanson; B Jacobsson; U Jodal; H Leffler; C S Edén
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

View more
  2 in total

1.  [Comments on the therapy and prevention of urinary tract infections in children].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-10       Impact factor: 0.639

2.  Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.

Authors:  G Elhanan; H Tabenkin; R Yahalom; R Raz
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.